相似文献
1
Preparing for COVID-19-related Drug Shortages.应对与新冠病毒相关的药品短缺问题。
Ann Am Thorac Soc. 2020 Aug;17(8):928-931. doi: 10.1513/AnnalsATS.202004-362VP.
2
Estimating Shortages in Capacity to Deliver Continuous Kidney Replacement Therapy During the COVID-19 Pandemic in the United States.估算美国在 COVID-19 大流行期间连续肾脏替代疗法提供能力短缺。
Am J Kidney Dis. 2020 Nov;76(5):696-709.e1. doi: 10.1053/j.ajkd.2020.07.005. Epub 2020 Jul 28.
3
Medication Shortages During the COVID-19 Crisis: What We Must Do.新冠疫情危机期间的药品短缺：我们必须采取的措施。
Mayo Clin Proc. 2020 Jun;95(6):1112-1115. doi: 10.1016/j.mayocp.2020.04.001. Epub 2020 Apr 3.
4
Ensuring Access to Medications in the US During the COVID-19 Pandemic.在新冠疫情期间确保美国民众获得药物治疗
JAMA. 2020 Jul 7;324(1):31-32. doi: 10.1001/jama.2020.6016.
5
Cardiovascular Collateral Damages at the Time of COVID-19.2019冠状病毒病期间的心血管 collateral 损伤
Can J Cardiol. 2020 Aug;36(8):1327.e7. doi: 10.1016/j.cjca.2020.06.011. Epub 2020 Jun 22.
6
Shortage of sedatives and neuromuscular blockers during COVID-19 pandemic: The result of an overstocking procedure in French hospitals?新冠疫情期间镇静剂和神经肌肉阻滞剂的短缺：法国医院过度储备程序的结果？
Anaesth Crit Care Pain Med. 2020 Oct;39(5):585-586. doi: 10.1016/j.accpm.2020.06.013. Epub 2020 Jun 30.
7
On New Zealand's weak, strong and muddled management of a COVID-19 epidemic.论新西兰对新冠疫情的疲弱、有力及混乱应对。
Intern Med J. 2020 Aug;50(8):901-904. doi: 10.1111/imj.14928.
8
The Italian Outbreak of COVID-19: Conditions, Contributors, and Concerns.意大利的新冠疫情：状况、成因及担忧
Mayo Clin Proc. 2020 Jun;95(6):1116-1118. doi: 10.1016/j.mayocp.2020.04.003. Epub 2020 Apr 10.
9
COVID-19, Mental Health and Aging: A Need for New Knowledge to Bridge Science and Service.新型冠状病毒肺炎、心理健康与老龄化：需要新知识来弥合科学与服务之间的差距
Am J Geriatr Psychiatry. 2020 Jul;28(7):695-697. doi: 10.1016/j.jagp.2020.03.007. Epub 2020 Mar 25.
10
Covid-19 in Italy: A Lesson to be Learned.意大利的新冠疫情：一个值得汲取的教训。
Rev Bras Ginecol Obstet. 2020 Jun;42(6):369-370. doi: 10.1055/s-0040-1713410. Epub 2020 Jun 30.
引用本文的文献
1
The effect of COVID-19 pandemic on perioperative factors: data from the Swedish Perioperative Register.2019冠状病毒病大流行对围手术期因素的影响：来自瑞典围手术期登记处的数据。
Perioper Med (Lond). 2023 Sep 16;12(1):50. doi: 10.1186/s13741-023-00340-0.
2
Sedation with Sevoflurane versus Propofol in COVID-19 Patients with Acute Respiratory Distress Syndrome: Results from a Randomized Clinical Trial.七氟醚与丙泊酚用于新型冠状病毒肺炎急性呼吸窘迫综合征患者镇静的随机临床试验结果
J Pers Med. 2023 May 31;13(6):925. doi: 10.3390/jpm13060925.
3
Psychological Morbidity After COVID-19 Critical Illness.新冠后危重症患者的心理病态。
Chest. 2023 Jan;163(1):139-147. doi: 10.1016/j.chest.2022.09.035. Epub 2022 Oct 3.
4
Drug shortage management: A qualitative assessment of a collaborative approach.药品短缺管理：合作方法的定性评估。
PLoS One. 2021 Apr 23;16(4):e0243870. doi: 10.1371/journal.pone.0243870. eCollection 2021.
5
The Pandemic and the Supply Chain: Gaps in Pharmaceutical Production and Distribution.大流行与供应链：药品生产与分销的差距
Am J Public Health. 2021 Apr;111(4):635-639. doi: 10.2105/AJPH.2020.306138. Epub 2021 Jan 28.
6
Drug Shortage and Critical Medication Inventory Management at a Children's Hospital During the COVID-19 Pandemic.新冠疫情期间一家儿童医院的药品短缺与关键药品库存管理
J Pediatr Pharmacol Ther. 2021;26(1):21-25. doi: 10.5863/1551-6776-26.1.21. Epub 2021 Jan 4.
本文引用的文献
1
Potential Shortages of Hydroxychloroquine for Patients with Lupus During the Coronavirus Disease 2019 Pandemic.2019年冠状病毒病大流行期间狼疮患者羟氯喹的潜在短缺情况。
JAMA Health Forum. 2020 Apr 1;1(4):e200438. doi: 10.1001/jamahealthforum.2020.0438.
2
Therapeutic alternatives and strategies for drug conservation in the intensive care unit during times of drug shortage: a report of the Ontario COVID-19 ICU Drug Task Force.在药物短缺时期加强医疗单位药物管理的治疗选择和策略：安大略省 COVID-19 加强医疗单位药物特别工作组的报告。
Can J Anaesth. 2020 Oct;67(10):1405-1416. doi: 10.1007/s12630-020-01713-5. Epub 2020 May 26.
3
Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.瑞德西韦的紧急使用授权：透明分配流程的必要性。
JAMA. 2020 Jun 16;323(23):2365-2366. doi: 10.1001/jama.2020.8863.
4
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.纽约州 COVID-19 患者住院死亡率与羟氯喹或阿奇霉素治疗的关联。
JAMA. 2020 Jun 23;323(24):2493-2502. doi: 10.1001/jama.2020.8630.
5
Ensuring Access to Medications in the US During the COVID-19 Pandemic.在新冠疫情期间确保美国民众获得药物治疗
JAMA. 2020 Jul 7;324(1):31-32. doi: 10.1001/jama.2020.6016.
6
Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19).拯救脓毒症运动：2019 冠状病毒病（COVID-19）危重症成人管理指南。
Intensive Care Med. 2020 May;46(5):854-887. doi: 10.1007/s00134-020-06022-5. Epub 2020 Mar 28.
7
Fair Allocation of Scarce Medical Resources in the Time of Covid-19.新冠疫情期间稀缺医疗资源的公平分配
N Engl J Med. 2020 May 21;382(21):2049-2055. doi: 10.1056/NEJMsb2005114. Epub 2020 Mar 23.
8
From Containment to Mitigation of COVID-19 in the US.从美国对新冠疫情的遏制到缓解
JAMA. 2020 Apr 21;323(15):1441-1442. doi: 10.1001/jama.2020.3882.
9
When Pigs Fly: A Multidisciplinary Approach to Navigating a Critical Heparin Shortage.当猪能飞的时候：跨学科方法应对关键肝素短缺。
Oncologist. 2020 Apr;25(4):334-347. doi: 10.1634/theoncologist.2019-0910. Epub 2020 Mar 10.
10
Teaching Trainees to Prescribe During the Public Health Crisis of Critical Medication Shortages.在关键药物短缺的公共卫生危机期间培训实习生进行处方开具。
J Grad Med Educ. 2020 Feb;12(1):44-45. doi: 10.4300/JGME-D-19-00966.1.
Zotero 插件